SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Mary Seacole

PatientMary Seacole
Date of birth1954-11-23
IdentifiersMRN HR-NI027-SYN; SSN (made up) 000-27-4483
Document date2026-09-14
AuthorAdwoa Fairweather-Kent, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month review. [S]

History of Present Illness

Mary Seacole returns two months after her annual wellness visit and six months after her first visit. Her home readings average 126/74 on amlodipine and losartan, with no dizziness on standing and only slight evening ankle swelling. She has had no falls. She walks 20 minutes most days with her cane, goes to tai chi twice a week and to the lunch club, and has lost 2 kg. Her knee pain is 3 out of 10. Her bone density scan showed osteopenia (lowest T-score -1.7 at the left femoral neck) with a 10-year hip fracture risk of 1.4%, below the level at which medicine is advised. Her mammogram, stool test and hepatitis C test were normal. She would like her vaccines today. [S]

ElementDetail
Home readingsAverage 126/74 mmHg
FallsNone
KneesPain 3 out of 10; walking 20 minutes most days
ScreeningOsteopenia below the treatment threshold; mammogram, stool test and hepatitis C normal

Review of Systems

SystemResultFinding
CardiovascularNegativeNo dizziness on standing, chest pain or breathlessness; slight evening ankle swelling
NeurologicalNegativeNo headaches, weakness or numbness
MusculoskeletalPositiveKnee pain 3 out of 10; no muscle aches on atorvastatin

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day4 g to each knee up to four times a dayTopical route2026-03-09activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-16activeS
Chlorthalidone 12.5 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-03-16 to 2026-05-11completedS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-04-13activeS
Losartan 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-14Body height157cmS
2026-09-14Body weight76kgS
2026-09-14Body mass index (BMI) [Ratio]30.8kg/m2S
2026-09-14Systolic blood pressure128mm[Hg]S
2026-09-14Diastolic blood pressure76mm[Hg]S
2026-09-14Heart rate72/minS
2026-09-14Respiratory rate16/minS
2026-09-14Body temperature36.6CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-14Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-09-14Total interval score [KOOSJR]66.2{score}S

Physical Exam

Vital signs recorded on 2026-09-14; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 128/76 seated, 126/74 standing at three minutes, pulse 72; weight 76.0 kg
CardiovascularRegular rhythm; trace ankle edema
MusculoskeletalNo knee effusion; Timed Up and Go 12 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmedresolvedprovisional R03.0S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health.
Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney diseaseactiveconfirmed I10S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension.
Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imagingactiveconfirmed M17.0S — Synthetic modern problem; not a claim about her real health.
Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 secondsactiveconfirmed Z91.81S — Synthetic fall-risk problem.
Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her kneesactiveconfirmed E66.811S — Synthetic modern problem; her self-description as stout is documented, her weight is not.
Thiazide-associated hyponatremia (sodium 129 mmol/L) and hypokalemia (potassium 3.3 mmol/L) with orthostatic hypotension and a near-fall, after four days of a cold with little food while taking chlorthalidone; no confusion; resolved after chlorthalidone was stoppedresolvedconfirmed E87.1S — Synthetic adverse drug event at an unscheduled visit; a common effect of thiazide diuretics in older women, not a historical diagnosis.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHgEvery visitCompleted today128/76 mmHg; home average 126/74: at target
ExaminationOrthostatic blood pressure (lying and standing)Every visitCompleted todayNo orthostatic drop
ExaminationWeight and BMI (5% weight-loss goal for knee osteoarthritis)Every visitCompleted today76.0 kg, BMI 30.8 (2.6% loss)
ExaminationCardiac auscultation and edemaEvery visitCompleted todayTrace ankle edema
LaboratorySodium, potassium, creatinine and eGFRTwo to four weeks after starting or changing a diuretic or ARB; then every six months on these medicinesUp to datePotassium 4.4 mmol/L and creatinine 0.98 mg/dL four weeks after losartan, at the wellness visit; next in six months
LaboratoryLipid panelFour to twelve weeks after starting a statin, then yearlyUp to dateLDL 82 mg/dL at the three-month review; next in a year
LaboratoryUrine albumin-to-creatinine ratio, hemoglobin A1c and TSHAt diagnosis, then yearlyUp to dateNormal six months ago; due in six months
SurveyDepression screen (PHQ-9)YearlyUp to datePHQ-9 6 at the geriatric assessment; PHQ-2 1 at the wellness visit
SurveyKnee pain score (0 to 10)Every visitCompleted today3 out of 10
SurveyKnee function (KOOS JR)Every visitCompleted todayKOOS JR 66.2
ExaminationKnee examination (range of motion, effusion, alignment, crepitus)Every visitCompleted todayNo effusion
Self-managementExercise therapy, tai chi and self-managementOngoingCompleted todayTai chi twice a week; walks 20 minutes most days
Medication safetyNSAID safety (topical diclofenac; no oral NSAIDs)Every visitCompleted todayDiclofenac gel only
ExaminationSTEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balanceAt diagnosis of fall risk, then yearly or with a fallCompleted todayTimed Up and Go 12 seconds; no falls
ImagingBone density (DXA) and fracture riskWomen 65 and older; repeat by fracture riskCompleted todayOsteopenia, lowest T-score -1.7; 10-year hip fracture risk 1.4%, major osteoporotic fracture 8%: no medicine
Self-managementHer own remedies: interactions and how she uses themEvery visitCompleted todayLiquorice still paused; ginger tea and liniment
Self-managementLoneliness, costs and transportEvery visitCompleted todayTai chi and lunch club; loneliness score improving; costs manageable
Self-managementInfluenza and other vaccinesYearly for influenzaCompleted todayHigh-dose influenza vaccine, Tdap and zoster dose 2 today

Goal progress:

Immunizations given today: Recombinant zoster vaccine, dose 2 of 2; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Influenza vaccine, high-dose [S]

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); Licorice Root (2026); Ginger (2026); CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026); Osteoporosis to Prevent Fractures: Screening (2025); Adult Immunization Schedule by Age (2026)

Follow-up: Review in three months; metabolic panel and urine albumin in six months. COVID-19 vaccine this autumn. Call for any fall, dizziness or sudden weakness, numbness or trouble speaking (call 999 at once). [S]